Tamer El-Sayed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tamer El-Sayed has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Ashwin Sivaharan
The Newcastle Vascular Centre, Freeman Hospital, Freeman Rd, High Heaton, Newcastle upon Tyne, NE7 7DN
4 shared publications Sandip Nandhra
3 shared publications- Sandip Nandhra
Population Health Sciences Institute, Newcastle University , Newcastle-upon-Tyne
3 shared publications - Yousef Yousef
Newcastle Vascular Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust, UK
3 shared publications - Albagir Altahir2 shared publications
- Haytham Hamid2 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by Elsevier in Journal of Vascular and Interventional Radiology
Stent Configurations in Aortoiliac Occlusive disease: A Systematic Review and Meta-Analysis
- 31 October 2026
- Published by Elsevier in Journal of Vascular and Interventional Radiology
Open AccessStent Configurations in Aortoiliac Occlusive disease: A Systematic Review and Meta-Analysis
- Open Access
- 4 September 2026
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 134, 329-337
Anemia Prevalence, Characterization, and Clinical Impact in Intermittent Claudication
- 4 September 2026
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 134, 329-337
Open AccessAnemia Prevalence, Characterization, and Clinical Impact in Intermittent Claudication
- Open Access
- 28 July 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
Contemporary Management of Isolated Iliac Aneurysms: Protocol for Systematic Review and Meta-analysis (Preprint)
- 28 July 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
Open AccessContemporary Management of Isolated Iliac Aneurysms: Protocol for Systematic Review and Meta-analysis (Preprint)
- Open Access
- 28 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Contemporary Management of Isolated Iliac Aneurysms: Protocol for Systematic Review and Meta-analysis (Preprint)
BACKGROUND Isolated iliac artery aneurysms (IIAAs) are uncommon, accounting for 2-7% of all abdominal arterial aneurysms. Historically, the mainstay of treatment had been open surgical repair (OSR), but recent advancements in endovascular interventions such as endovascular aneurysm repair (EVAR), iliac stent grafting, and embolisation techniques have improved clinical outcomes. However, there remains a need for clarity regarding the comparative effectiveness, risks, and long-term outcomes of different management approaches. This systematic review and meta-analysis aim to provide a comprehensive assessment of contemporary management strategies for IIAAs. OBJECTIVE This review aims to evaluate the current body of evidence on the 30-day major adverse cardiovascular events (MACE), aneurysm-related mortality, reintervention rate, long-term mortality, and length of hospital stay following endovascular repair and OSR. METHODS A literature search will be conducted in OVID Medline, EMBASE, SCOPUS, Cochrane Library, and ClinicalTrials.gov. Eligible studies include randomised and non-randomised controlled trials and observational studies. The primary outcome is 30-day major adverse cardiovascular events (MACE). The secondary outcomes are aneurysm-related mortality, reintervention rate, long-term mortality, and length of hospital stay. The Cochrane RoB2 tool for randomised controlled trials and Newcastle-Ottawa scale tool for observational trials will be used to assess bias. A meta-analysis of clinically homogenous studies will be performed using RevMan. A narrative systematic summary will be performed for data not amenable to meta-analysis. RESULTS Pilot work, formal searching, and study identification commenced on 23rd July 2025. Screening search results against inclusion and exclusion criteria is currently ongoing, which will be followed by data extraction, risk of bias and quality assessments, and data synthesis. We anticipate submitting the manuscript for peer review by the end of September 2025. CONCLUSIONS This review will synthesise current evidence on the contemporary management strategies for IIAAs. CLINICALTRIAL PROSPERO CRD420250572416; https://www.crd.york.ac.uk/PROSPERO/view/CRD420250572416
- 28 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessContemporary Management of Isolated Iliac Aneurysms: Protocol for Systematic Review and Meta-analysis (Preprint)
BACKGROUND Isolated iliac artery aneurysms (IIAAs) are uncommon, accounting for 2-7% of all abdominal arterial aneurysms. Historically, the mainstay of treatment had been open surgical repair (OSR), but recent advancements in endovascular interventions such as endovascular aneurysm repair (EVAR), iliac stent grafting, and embolisation techniques have improved clinical outcomes. However, there remains a need for clarity regarding the comparative effectiveness, risks, and long-term outcomes of different management approaches. This systematic review and meta-analysis aim to provide a comprehensive assessment of contemporary management strategies for IIAAs. OBJECTIVE This review aims to evaluate the current body of evidence on the 30-day major adverse cardiovascular events (MACE), aneurysm-related mortality, reintervention rate, long-term mortality, and length of hospital stay following endovascular repair and OSR. METHODS A literature search will be conducted in OVID Medline, EMBASE, SCOPUS, Cochrane Library, and ClinicalTrials.gov. Eligible studies include randomised and non-randomised controlled trials and observational studies. The primary outcome is 30-day major adverse cardiovascular events (MACE). The secondary outcomes are aneurysm-related mortality, reintervention rate, long-term mortality, and length of hospital stay. The Cochrane RoB2 tool for randomised controlled trials and Newcastle-Ottawa scale tool for observational trials will be used to assess bias. A meta-analysis of clinically homogenous studies will be performed using RevMan. A narrative systematic summary will be performed for data not amenable to meta-analysis. RESULTS Pilot work, formal searching, and study identification commenced on 23rd July 2025. Screening search results against inclusion and exclusion criteria is currently ongoing, which will be followed by data extraction, risk of bias and quality assessments, and data synthesis. We anticipate submitting the manuscript for peer review by the end of September 2025. CONCLUSIONS This review will synthesise current evidence on the contemporary management strategies for IIAAs. CLINICALTRIAL PROSPERO CRD420250572416; https://www.crd.york.ac.uk/PROSPERO/view/CRD420250572416
- Open Access
A multicentre prospective observational study to investigate the prevalence and short-term impact of frailty, sarcopenia, anaemia and multiple long term health conditions in chronic limb threatening ischaemia (CLTI) - The FraiLTI (Frailty in Chronic Limb Threatening Ischaemia) Study
Background: CLTI is a life and limb threatening condition that is associated with a gradual overall decline in health which remains under-explored. We explore the prevalence of correlated conditions (frailty, sarcopenia and anaemia) in patients with CLTI and assess their ability to perform activities of daily living (ADLs) alongside multiple long term health conditions (MLTC), polypharmacy and clinical outcomes. Methods: FraiLTI was a UK multi-centre, prospective, observational study, evaluating the prevalence of frailty (Rockwood Clinical Frailty score of ≥5), sarcopenia based on low handgrip strength (<27kg for men and <16kg for women). and anaemia in patients admitted to hospital with chronic limb threatening ischaemia (CLTI). Other outcomes included prevalence of polypharmacy (≥5 medications) and MLTC (≥2 long-term health conditions). Recruitment took place from October 2021 to October 2022 in six UK centres supported by the Vascular and Endovascular Research Network and funded by the National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) North-East. Results: 84 patients were included in the study (54 [64.3%] men), with a mean (SD) age of 71.5 (11) years. 43/83 (51.8%) patients were living with frailty. 27/81 (33.3%) patients had probable sarcopenia 43/80 (53.8%) patients had anaemia of which 35 (92.1%) had normocytic anaemia. There was no difference in 90-day amputation-free survival for those living with or without frailty (97.6% vs 94.8%, p=0.78), sarcopenia (100% vs 94.4%, p=0.58), or anaemia (95.1% vs 97.3% vs p=0.45). MLTC were present in 57 (67.9%) patients and 67 (79.8%) patients met the definition of polypharmacy. Conclusion: Frailty, sarcopenia and anaemia are highly prevalent in those with CLTI but none of these factors were associated with amputation free survival in this study. This has highlighted that the management of CLTI patients extends beyond revascularisation alone. Article Highlights: Type of research: Multi-centre, prospective, observational study. Key Findings: The prevalence of frailty (51.8%), anaemia (53.8%), and sarcopenia (33.3%) is high in people with CLTI. Most patients with CLTI had multiple long-term conditions (MLTC) (67.9%) or polypharmacy (79.8%). Take home Message: This study shows that frailty, sarcopenia and anaemia are highly prevalent in those with CLTI. The management of CLTI patients extends beyond revascularisation alone. Table of contents Summary: This study shows that frailty, sarcopenia and anaemia are highly prevalent in those with CLTI. The management of CLTI patients extends beyond revascularisation alone.
Open AccessA multicentre prospective observational study to investigate the prevalence and short-term impact of frailty, sarcopenia, anaemia and multiple long term health conditions in chronic limb threatening ischaemia (CLTI) - The FraiLTI (Frailty in Chronic Limb Threatening Ischaemia) Study
Background: CLTI is a life and limb threatening condition that is associated with a gradual overall decline in health which remains under-explored. We explore the prevalence of correlated conditions (frailty, sarcopenia and anaemia) in patients with CLTI and assess their ability to perform activities of daily living (ADLs) alongside multiple long term health conditions (MLTC), polypharmacy and clinical outcomes. Methods: FraiLTI was a UK multi-centre, prospective, observational study, evaluating the prevalence of frailty (Rockwood Clinical Frailty score of ≥5), sarcopenia based on low handgrip strength (<27kg for men and <16kg for women). and anaemia in patients admitted to hospital with chronic limb threatening ischaemia (CLTI). Other outcomes included prevalence of polypharmacy (≥5 medications) and MLTC (≥2 long-term health conditions). Recruitment took place from October 2021 to October 2022 in six UK centres supported by the Vascular and Endovascular Research Network and funded by the National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) North-East. Results: 84 patients were included in the study (54 [64.3%] men), with a mean (SD) age of 71.5 (11) years. 43/83 (51.8%) patients were living with frailty. 27/81 (33.3%) patients had probable sarcopenia 43/80 (53.8%) patients had anaemia of which 35 (92.1%) had normocytic anaemia. There was no difference in 90-day amputation-free survival for those living with or without frailty (97.6% vs 94.8%, p=0.78), sarcopenia (100% vs 94.4%, p=0.58), or anaemia (95.1% vs 97.3% vs p=0.45). MLTC were present in 57 (67.9%) patients and 67 (79.8%) patients met the definition of polypharmacy. Conclusion: Frailty, sarcopenia and anaemia are highly prevalent in those with CLTI but none of these factors were associated with amputation free survival in this study. This has highlighted that the management of CLTI patients extends beyond revascularisation alone. Article Highlights: Type of research: Multi-centre, prospective, observational study. Key Findings: The prevalence of frailty (51.8%), anaemia (53.8%), and sarcopenia (33.3%) is high in people with CLTI. Most patients with CLTI had multiple long-term conditions (MLTC) (67.9%) or polypharmacy (79.8%). Take home Message: This study shows that frailty, sarcopenia and anaemia are highly prevalent in those with CLTI. The management of CLTI patients extends beyond revascularisation alone. Table of contents Summary: This study shows that frailty, sarcopenia and anaemia are highly prevalent in those with CLTI. The management of CLTI patients extends beyond revascularisation alone.
- 27 July 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 66 (4) , 601-602
Incidentally Discovered Fractured Proximal Nitinol Ring in Fenestrated Anaconda Stent Graft Device: an Important Radiographic Finding
- 27 July 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 66 (4) , 601-602
Incidentally Discovered Fractured Proximal Nitinol Ring in Fenestrated Anaconda Stent Graft Device: an Important Radiographic Finding